2004
DOI: 10.1002/jmv.20269
|View full text |Cite
|
Sign up to set email alerts
|

All CVB serotypes and clinical isolates induce irreversible cytopathic effects in primary cardiomyocytes

Abstract: Coxsackievirus B3 (CVB3) has been identified as a major causative agent of acute and chronic myocarditis, but the involvement of other CVB serotypes in myocarditis has not been investigated. To dissect the pathological properties of different CVB serotypes toward primary cardiomyocytes, we tested their effects on primary cardiomyocyte cultures from neonatal rats. Morphological abnormalities were examined by both light and fluorescence microscopy after Hoechst 33342 staining, and loss of cell viability was esti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0
1

Year Published

2007
2007
2022
2022

Publication Types

Select...
8
1

Relationship

4
5

Authors

Journals

citations
Cited by 20 publications
(12 citation statements)
references
References 27 publications
(28 reference statements)
0
11
0
1
Order By: Relevance
“…Two recent publications suggest that the presence of CVB in the heart relies upon the generation of noncytolytic variants with 5Ј terminal mutations and deletions (35,38). Yet it is not clear from this study if attenuated, noncytolytic variants are found in human patients and how these variants may out-compete wildtype virus, assuming that CVB grows without major impediments in cardiomyocytes, as has been shown in vitro (2,30,39). Furthermore, recent data suggest that engineered deletions of the 5Ј UTR of an infectious CVB3 clone (similar, although not identical, to those identified by Kim et al) failed to give rise to infectious progeny or detectable levels of viral protein expression (33).…”
Section: Discussionmentioning
confidence: 86%
“…Two recent publications suggest that the presence of CVB in the heart relies upon the generation of noncytolytic variants with 5Ј terminal mutations and deletions (35,38). Yet it is not clear from this study if attenuated, noncytolytic variants are found in human patients and how these variants may out-compete wildtype virus, assuming that CVB grows without major impediments in cardiomyocytes, as has been shown in vitro (2,30,39). Furthermore, recent data suggest that engineered deletions of the 5Ј UTR of an infectious CVB3 clone (similar, although not identical, to those identified by Kim et al) failed to give rise to infectious progeny or detectable levels of viral protein expression (33).…”
Section: Discussionmentioning
confidence: 86%
“…We previously found that EVs, including CVA24 and CVB3, efficiently replicate in a wide variety of cells, resulting in an induction of cytotoxicity and a loss of viable cells [30][31][32] . Indeed, EV replication has been found to shut down the normal function of host cells and is directly linked to disease.…”
Section: Discussionmentioning
confidence: 99%
“…Immunocytochemistry was performed essentially as described previously [Ahn et al, 2005a]. Cells were fixed with 4% paraformaldehyde, permeabilized with 0.05% TritonX-100 in 0.1 M phosphate buffer (pH 7.4).…”
Section: Immunocytochemistry and Immunoblotting Analysismentioning
confidence: 99%